n-(1-methyl-2-phenylethyl)adenosine has been researched along with Heart Disease, Ischemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harrison, GJ; Headrick, JP; Rose'Meyer, RB | 1 |
| Pisarenko, OI; Ruuge, EK; Serebryakova, LI; Studneva, IM; Timoshin, AA; Tskitishvily, OV | 1 |
2 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and Heart Disease, Ischemic
| Article | Year |
|---|---|
Enhanced adenosine A(2B) mediated coronary response in reserpinised rat heart.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Flavins; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Myocardium; Norepinephrine; Purines; Rats; Rats, Wistar; Reperfusion; Reserpine; Time Factors; Tyramine; Vasodilator Agents | 2003 |
Metabolic and antioxidant effects of R(+/-)-N6-(2-phenylisopropyl)-adenosine following regional ischemia and reperfusion in canine myocardium.
Topics: Adenosine; Animals; Antioxidants; Dogs; Female; Hemodynamics; Hydroxyl Radical; Male; Microdialysis; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Spin Labels; Vasodilator Agents | 1997 |